Sponsor Dossier
Arrotex Pharmaceuticals
Sponsor Dossier for Arrotex Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABACAVIR/LAMIVUDINE
- Brand: ACARBOSE
- Brand: ACICLOVIR AN
- Brand: Actacode
- Brand: ACTILAX
- Brand: AGILOCAM
- Brand: AH
- Brand: ALENDRO
- Device (sponsor): Lubricant, eye
- Device (sponsor): Nail treatment solution
- Device (sponsor): Cold treatment spray
- Device (sponsor): Cryogenic spray, cutaneous
- Device (sponsor): Nail treatment solution
- Device (sponsor): Irrigation fluid, nasal
- Device (sponsor): Sexual lubricant
- Device (sponsor): Lubricant, eye
- Device (sponsor): Irrigation kit, nasal
- Device (sponsor): Irrigation fluid, nasal
- Device (sponsor): Nail treatment solution
About
Arrotex Pharmaceuticals is an Australian Private Company with ABN 30605552234, registered in Victoria. The company is currently active and registered for GST.
Portfolio
Arrotex Pharmaceuticals has 1004 brands on the ARTG, of which 439 are indexable and 390 carry a Product Information document. 337 brands are PBS-listed, 27 have a PBAC outcome on record, and 4 have an AusPAR on record. Notable brands include ABACAVIR/LAMIVUDINE, ACARBOSE, ACICLOVIR AN, Actacode, ACTILAX, AGILOCAM, AH, ALENDRO, Alendronate Plus D3, ALIPIX, ALLEGRON, ALLEREZE.
Therapeutic focus
— Cardiology: 218 brands — Neurology: 137 brands — Psychiatry: 118 brands — Infectious Disease: 116 brands — Pain Management: 52 brands — Endocrinology: 51 brands — Oncology: 45 brands — Reproductive Health: 44 brands — Gastroenterology: 44 brands — Musculoskeletal: 37 brands — Ophthalmology: 32 brands — Dermatology: 27 brands — Immunology: 22 brands — Respiratory: 21 brands — Complementary Medicine: 13 brands — Haematology: 10 brands — Renal: 7 brands — Other: 5 brands — Hepatology: 4 brands — Rare Disease: 1 brand
PBS footprint
337 brands are PBS-listed, with the latest PBS schedule date 2026-11-01.
Regulatory activity
The latest PBAC outcome is 2026-03-01, across 27 brands with a PBAC outcome on record. The latest AusPAR is 2021-09-21, across 4 brands with an AusPAR on record.